R(+)XK469

DRUG3 trials

Conditions

Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)Adult Acute Myeloblastic Leukemia With Maturation (M2)Adult Acute Myeloblastic Leukemia Without Maturation (M1)

Phase 1

R(+)XK469 in Treating Patients With Advanced Neuroblastoma

CompletedNCT00028522

National Cancer Institute (NCI)Disseminated Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma +1

Start: 2001-12-31Updated: 2013-12-16

XK469 in Treating Patients With Advanced Solid Tumors

CompletedNCT00028548

Barbara Ann Karmanos Cancer InstituteUnspecified Adult Solid Tumor, Protocol Specific

Start: 2002-01-31End: 2006-12-31Updated: 2014-04-25

XK469R in Treating Patients With Refractory Hematologic Cancer

CompletedNCT00095797

National Cancer Institute (NCI)Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) +26

Start: 2004-10-31Updated: 2013-02-08

R(+)XK469

Sponsors

Conditions

Phase 1